{"id":"NCT00434161","sponsor":"Swedish Orphan Biovitrum","briefTitle":"A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma","officialTitle":"A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin for Reduction in Severity of Oral Mucositis in Subjects With Multiple Myeloma Receiving Melphalan Followed by Autologous Blood Stem Cell Transplantation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2009-03","completion":"2012-05","firstPosted":"2007-02-12","resultsPosted":"2015-03-10","lastUpdate":"2015-03-30"},"enrollment":281,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Palifermin before only","otherNames":["Kepivance"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Palifermin before and after","otherNames":["Kepivance"]}],"arms":[{"label":"Palifermin before only","type":"ACTIVE_COMPARATOR"},{"label":"Placebo (suger pill)","type":"PLACEBO_COMPARATOR"},{"label":"Palifermin before and after","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the efficacy and effect of palifermin on the incidence of oral mucositis in subjects with multiple myeloma receiving Melphalan followed by autologous peripheral blood stem cell transplantation. Amendment 01 (April 07) introduced three cataract assessments to be carried out at Screening, Month 6 and Month 12 in response to FDA and EMEA follow up measures.","primaryOutcome":{"measure":"Maximum Severity of Oral Mucositis (World Health Organization (WHO) Grades 0/1, 2, 3, or 4)","timeFrame":"at Day 32","effectByArm":[{"arm":"Palifermin Before Only","deltaMin":79,"sd":null},{"arm":"Placebo","deltaMin":36,"sd":null},{"arm":"Palifermin Before and After","deltaMin":68,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":"0.188"},{"comp":"OG000 vs OG001","p":"0.468"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":14},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":111},"commonTop":["Nausea","Diarrhoea","Pyrexia","Vomiting","Rash"]}}